| Program Chair |
|
Alla Kloss |
Sanofi |
|
|
Susan Abbatiello |
Thermo Fisher Scientific |
| Dave Abramowitz |
SCIEX |
| Bradley Ackermann |
Eli Lilly & Company |
| Mark Arnold |
Covance |
| Lorin Bachmann |
Virginia Commonwealth |
| Kevin Bateman |
Merck |
| Chad Briscoe |
PRA Health Sciences |
| John Bulter |
Agilent Technologies |
| Mark Cancilla |
Merck |
| Helene Cardasis |
Thermo Fisher Scientific |
| Johnny Cardenas |
SCIEX |
|
Donald Chace |
Medolac Laboratories |
| Michelle Clasquin |
Pfizer |
|
Suzanne Cordovado |
Centers for Disease Control and Prevention |
| Shawn Davidson |
Princeton University |
| Dave Detlefsen |
Novatia |
|
Nicole Donnelly |
PharmaCadence Analytical Services |
|
Emily Ehrenfeld |
New Objective |
| Ayman El-Kattan |
IMF |
|
Joe Fox |
SCIEX |
|
Patrick Fromal |
Shimadzu |
| Timothy Garrett |
University of Florida |
| Hannah Glader |
Alturas Analytics |
| Mark Hail |
Novatia |
|
Mark Hayward |
Active Ingredient Technologies |
|
Lucinda Hittle |
Merck |
|
Scott Hottenstein |
GlaxoSmithKline |
|
Qin Ji |
Bristol-Myers Squibb |
|
Wenying Jian |
Janssen Research & Development |
|
John Kellie |
GlaxoSmithKline |
|
Kelli Jonakin |
SCIEX |
| Barry Jones |
Q2 Solutions |
|
Jonathan Josephs |
Thermo Fisher Scientific |
|
Olga Kavetskaia |
Pfizer |
| Rick King |
PharmaCadence Analytical Services |
| Michael Lassman |
Merck |
| Yurong Lai |
Gilead |
|
Ken Lewis |
OpAns |
|
Wenkui Li |
Novartis |
|
Guowen Liu |
Agios Pharmaceuticals |
| Linlin Luo |
Bristol-Myers Squibb |
|
Carla Marshall-Waggett |
New Objective |
|
Joshua Mann |
SOPHiA GENETICS |
|
Nicole Matz |
PRA Health Sciences |
|
Eric Milgram |
PepsiCo |
|
Ganesh Moorthy |
Children's Hopsital of Philadelphia |
|
Shane Needham |
Alturas Analytics |
|
Randall Nelson |
Arizona State University |
|
Timothy Olah |
Bristol-Myers Squibb |
|
Dave Pirman |
Agios Pharmaceuticals |
|
Joanna Pols |
Regeneron Pharmaceuticals |
|
Robyn Rourick |
Genentech |
|
Nalini Sadagopan |
Agilent Technologies |
| Jim Shen |
Bristol-Myers Squibb |
|
Petia Shipkova |
Bristol-Myers Squibb |
|
Joe Siple |
New Objective |
| James Small |
Merck |
| Daniel Spellman |
Merck |
| Neil Spooner |
Spooner Bioanalytical Solutions |
|
Matt Szapacs |
GlaxoSmithKline |
|
Stephen Tomisich |
Trajan Scientific & Medical |
|
Gary Valaskovic |
New Objective |
|
Roy Vaz |
Sanofi |
|
Sihe Wang |
Cleveland Clinic |
|
Naidong Weng |
Janssen Research & Development |
|
Helen Weng |
Frontage Laboratories |
| Clark Williard |
inVentiv Health |
| Enaksha Wickremsinhe |
Eli Lilly & Co. |
|
Eric Woolf |
Merck |
|
Sophia Xu |
Bristol-Myers Squibb |
|
Eric Yang |
GlaxoSmithKline |
|
Nathan Yates |
University of Pittsburgh |
|
Anthony Yeung |
Fox Chase Cancer Center |
|
Ismael Zamora |
Molecular Discovery |
|
Yi Zhang |
SCIEX |
Final Program